Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer

NCT03041285 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped have difficulty finding eligible participants

Conditions

Metastatic Castrate- Resistant Prostate Cancer

Interventions

DRUG: idronoxil (NOX66) suppository
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

Royal North Shore Hospital